Venture Catalysts exits D2C brand TruNativ at 12.7x return, 67% IRR on 2021 bet
Venture Catalysts has fully exited functional-foods brand TruNativ, realising a 12.73x return and 67% IRR over a five-year hold. TruNativ, known for heat-resistant whey protein tailored to Indian cooking, targets the country's expanding nutrition and wellness market.
What happened
Venture Catalysts fully exited D2C nutrition brand TruNativ, realising a 12.73x return and 67% IRR on its 2021 investment. TruNativ makes functional foods
Key facts
- 12.73x return
- 67% IRR
- 5-year hold
- 1.34x multiple
- 18% IRR
- 21 months
- $100,000-$2 million typical ticket
Why this matters
The full exit of a differentiated functional-foods brand like TruNativ signals active M&A and consolidation appetite in Indian D2C nutrition worth tracking for acquisition targets.
What to watch
- New D2C nutrition rounds closing above 8x forward revenue
- FMCG major announcing functional-foods acquisition or JV
- Retail media / quick-commerce shelf allocation shifts toward protein SKUs
- TruNativ post-exit ownership and expansion signals
- Rising CAC or discounting intensity in protein D2C category
- Map D2C nutrition brands at Series A/B with >2x repeat-purchase for pre-emptive positioning
- Track which FMCG/pharma majors add functional-foods M&A mandates
- Audit our own private-label protein SKU margins vs branded challengers
- Identify contract manufacturers of heat-stable protein formulations for supply-side leverage